MusclePharm Corporation filed second amended plan of reorganization with related disclosure statement in the US Bankruptcy Court on August 28, 2023. As per the plan filed, there are no changes in the treatment of any claim class or sources of plan funding.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000025 USD | +2,400.00% | 0.00% | +2,400.00% |
1st Jan change | Capi. | |
---|---|---|
+2,400.00% | 836 | |
+76.43% | 5.87B | |
+2.76% | 988M | |
+46.03% | 955M | |
+2.49% | 669M | |
-.--% | 600M | |
-2.15% | 593M | |
+10.28% | 536M | |
-.--% | 500M | |
-2.10% | 470M |
- Stock Market
- Equities
- MSLP Stock
- News MusclePharm Corporation
- Second Amended Reorganization Plan and Disclosure Statement Filed by MusclePharm Corporation